As respiratory illnesses surge, the Dana-Farber Cancer Institute has opted for a return to protective measures, renewing the face mask mandate for staff, patients, and visitors effective this Monday. This action comes amidst a rise in cases of COVID-19, influenza, and RSV in the region, prompting officials to maintain the mandate for the "foreseeable future" to curb the spread of infections.
On their website, Dana-Farber officials explained the reinstatement is backed by hard data, including "rates of influenza-like illness, staff absenteeism, and emergency room visits and hospitalizations caused by respiratory viruses." With recent statistics indicating that acute respiratory illness was the culprit behind more than 15% of all hospital visits in Massachusetts this week, the concern grows as the state confronts a spike in COVID-19 cases in the early weeks of December, reporting over 4,000 weekly cases—a high for the current respiratory season, as Boston.com notes.
The hospital is advising anyone experiencing symptoms akin to colds, flu, or COVID-19, or those in close contact with individuals exhibiting these symptoms, to call before arriving for their appointments. The new policy’s duration remains indeterminate, with hospital officials stating that they will assess and adjust accordingly as infection rates change, as reported by NBC Boston.
While other major health institutions in Boston such as Boston Medical Center, Harvard Medical Center, and Mass General Brigham stay mask-optional, Dana-Farber has charted its own course under the guidance of its health experts in light of "current high rates of respirator illnesses." The institution is determined to lift the mask requirement only when they see a decrease in infection rates, thereby maintaining vigilant protection for their vulnerable patients, as confirmed by WHDH News in a statement provided by the hospital officials.
